Patents Assigned to Health Plus International Inc.
  • Patent number: 6861066
    Abstract: A method of manufacturing a stable nanosuspension for delivery of a biologically active agent into the bloodstream of a subject is disclosed. A microfluidizable mixture is initially formed and processed via a microfluidization process to form the stable nanosuspension, which may be administered via the buccal mucosa or other suitable routes of administration. This product demonstrates increased bioavailability, enhanced period of onset, and enhanced stability for a controlled-release product.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: March 1, 2005
    Assignee: Health Plus International Inc.
    Inventor: Russell Van de Casteele